World's Best Scientists 2026 revealed!
Edward A. Belongia

Edward A. Belongia

D-Index & Metrics

Immunology

D-Index
84
Citations
29933
World Ranking
1348
National Ranking
694

Medicine

D-Index
84
Citations
29935
World Ranking
14973
National Ranking
7567

Edward A. Belongia publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Edward A. Belongia sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 336 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Edward A. Belongia D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Edward A. Belongia sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Edward A. Belongia is affiliated with Marshfield Clinic in the United States and has an extensive research profile primarily in the field of Medicine. Their scholarly activity focuses on epidemiology and infectious diseases, with notable work in health, modeling and simulation, and neurology as subfields.

The main topics addressed in their research include:

  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy
  • COVID-19 epidemiological studies
  • COVID-19 Clinical Research Studies
  • Viral gastroenteritis research and epidemiology

Belongia's recent publications illustrate a focus on viral infections and vaccine effectiveness. Selected recent papers include:

  • "Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020" (2020), published in MMWR Morbidity and Mortality Weekly Report
  • "Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020" (2020), published in MMWR Morbidity and Mortality Weekly Report
  • "Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020" (2020), published in Clinical Infectious Diseases
  • "Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season" (2020), published in Clinical Infectious Diseases
  • "Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022" (2022), published in MMWR Morbidity and Mortality Weekly Report

Frequent co-authors in their work include:

  • Huong Q. McLean
  • Brendan Flannery
  • Manjusha Gaglani
  • Emily T. Martin
  • Jessie R. Chung

Belongia's research has been published widely in several venues, with most frequent publications in:

  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Influenza and Other Respiratory Viruses
  • Clinical Infectious Diseases

Best Publications

  • Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans

    Rebecca J. Garten;C. Todd Davis;Colin A. Russell;Colin A. Russell;Bo Shu

  • Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

    Michael T Osterholm;Nicholas S Kelley;Alfred Sommer;Edward A Belongia

  • National Institutes of Health consensus development conference statement: management of hepatitis B.

    Michael Floyd Sorrell;Edward A. Belongia;Jose Costa;Ilana F. Gareen

  • Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

    Kathleen L Dooling;Angela Guo;Manisha Patel;Grace M Lee

  • Transmission of SARS-COV-2 infections in households - Tennessee and Wisconsin, April-September 2020

    Carlos G Grijalva;Melissa A Rolfes;Yuwei Zhu;Huong Q McLean

  • Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

    Edward A Belongia;Melissa D Simpson;Jennifer P King;Maria E Sundaram

  • Coinfections Acquired from Ixodes Ticks

    Stephen J. Swanson;David Neitzel;Kurt D. Reed;Edward A. Belongia

  • An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use

    Edward A. Belongia;Craig W. Hedberg;Gerald J. Gleich;Karen E. White

  • Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

    Suzanne E. Ohmit;Mark G. Thompson;Joshua G. Petrie;Swathi N. Thaker

  • Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

    Nicola P. Klein;Bruce Fireman;W. Katherine Yih;Edwin Lewis

  • Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season

    Edward A. Belongia;Burney A. Kieke;James G. Donahue;Robert T. Greenlee

  • Transmission of Escherichia coli 0157:H7 Infection in Minnesota Child Day-care Facilities

    Edward A. Belongia;Michael T. Osterholm;John T. Soler;David A. Ammend

  • Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004.

    James R. Johnson;Mark R. Sannes;Cynthia Croy;Brian Johnston

  • Influenza vaccine effectiveness in the United States during the 2015-2016 season.

    Michael L. Jackson;Jessie R. Chung;Lisa A. Jackson;C. Hallie Phillips

  • The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety

    James Baggs;Julianne Gee;Edwin Lewis;Gabrielle Fowler

  • Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type

    Huong Q. McLean;Mark G. Thompson;Maria E. Sundaram;Burney A. Kieke

  • Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season.

    Melissa A Rolfes;Brendan Flannery;Jessie R Chung;Alissa O'Halloran

  • Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons

    Huong Q. McLean;Mark G. Thompson;Maria E. Sundaram;Jennifer K. Meece

  • Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains

    John J. Treanor;H. Keipp Talbot;Suzanne E. Ohmit;Laura A. Coleman

  • 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

    Richard K Zimmerman;Mary Patricia Nowalk;Jessie Chung;Michael L Jackson

  • Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season

    Brendan Flannery;Jessie R Chung;Arnold S Monto;Emily T Martin

Frequent Co-Authors

Huong Q. McLean
Huong Q. McLean Marshfield Clinic
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Manjusha Gaglani
Manjusha Gaglani Baylor College of Medicine
Brendan Flannery
Brendan Flannery Centers for Disease Control and Prevention
Richard K. Zimmerman
Richard K. Zimmerman University of Pittsburgh
Alicia M. Fry
Alicia M. Fry Emory University
Arnold S. Monto
Arnold S. Monto University of Michigan–Ann Arbor
Mary Patricia Nowalk
Mary Patricia Nowalk University of Pittsburgh
Jennifer K. Meece
Jennifer K. Meece Marshfield Clinic
Allison L. Naleway
Allison L. Naleway Kaiser Permanente

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology opens doors to various healthcare and research careers, often requiring additional specialized education. For healthcare professionals aiming to expand their scope, programs like acute care nurse practitioner programs offer a pathway to advanced clinical roles, particularly in high-intensity environments.

For those interested in accelerating their nursing career, accelerated paths such as the accelerated FNP provide efficient routes to becoming family nurse practitioners. These programs are ideal for students with a non-nursing background or those seeking a faster transition.

Non-nurses can also enter the field through quality online ADN programs for non nurses, which allow individuals to gain foundational nursing knowledge and clinical skills remotely. This option supports diverse learners aiming to join healthcare professions.

Additionally, for those pursuing a Bachelor of Science in Nursing, identifying the easiest ABSN programs to get into can make the entry process smoother without compromising the quality of education, enabling quicker progression toward immunology-focused careers or clinical practice.

Best Scientists Citing Edward A. Belongia

Trending Scientists

Recently Published Articles